Eupnoos is a London-based health-tech company that provides a software platform using smartphone-based acoustic analysis to screen for and monitor respiratory conditions like asthma and COPD without the need for additional hardware.
Eupnoos is a health-tech company that has developed a software system designed to transform smartphones into rapid, clinical-grade diagnostic tools for respiratory and cardiac conditions. The technology utilizes a smartphone's built-in microphone and camera to capture and analyze expiratory breath audio through physics-based, explainable artificial intelligence models. By identifying specific acoustic biomarkers, the platform differentiates between conditions such as airway obstruction and heart failure or screens for diseases like asthma and COPD. The system includes features such as a 'magic mirror' computer vision interface to guide users through testing, eliminating the need for specialized hardware or trained clinical technicians to perform standard lung function assessments.
This technology provides significant value to healthcare providers, telehealth services, and patients by enabling objective, real-time symptom assessment and monitoring in non-clinical environments. By simplifying the diagnostic pathway and facilitating remote management, Eupnoos aims to reduce unnecessary clinical referrals and help clinicians initiate targeted therapies faster. The system is designed to be highly scalable and can be integrated via APIs into existing health platforms, supporting better population health surveillance and personalized patient care in diverse settings ranging from community clinics to home-based care.